Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer - the Indiana University experience

By Behnia M.   Foster R.   Einhorn L.H.   Donohue J.   Nichols C.R.  

European Journal of Cancer, Vol. 36, Iss. 4, 2000-03 ,pp. : 472-475

Elsevier

Access to resources Recommend Favorite

Stage I non-seminomatous germ-cell tumours of the testis - identification of a subgroup of patients with a very low risk of relapse

By Alexandre J.   Fizazi K.   Mahe C.   Culine S.   Droz J.-P.   Theodore C.   Terrier-Lacombe M.-J.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 576-582

Elsevier

Access to resources Recommend Favorite

Non-seminomatous ovarian germ cell tumours in children

By Baranzelli M.C.   Bouffet E.   Quintana E.   Portas M.   Thyss A.   Patte C.  

European Journal of Cancer, Vol. 36, Iss. 3, 2000-02 ,pp. : 376-383

Elsevier

Access to resources Recommend Favorite

Chemotherapy in Stage II Nonseminomatous Germ Cell Tumors of the Testis: The Institut Gustave Roussy Experience

By Culine S.   Theodore C.   Terrier-Lacombe M.J.   Droz J.-P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 5, 1995-09 ,pp. : 175-183

Elsevier

Access to resources Recommend Favorite

Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT)

By Donohue J.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite